Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.02
0.010.99%
At close: -
$1.07
0.054.90%
After Hours: May 21, 4:36 PM EDT
Comments
Loading...
Opus Genetics Analyst Ratings and Price Targets | NASDAQ:IRD | Benzinga
Opus Genetics Inc has a consensus price target of $7.33 based on the ratings of 3 analysts. The high is $8 issued by Jones Trading on April 1, 2025. The low is $6 issued by Craig-Hallum on April 11, 2025. The 3 most-recent analyst ratings were released by Craig-Hallum, Jones Trading, and HC Wainwright & Co. on April 11, 2025, April 1, 2025, and April 1, 2025, respectively. With an average price target of $7.33 between Craig-Hallum, Jones Trading, and HC Wainwright & Co., there's an implied 585.36% upside for Opus Genetics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
Jones Trading
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Opus Genetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/11/2025 | Buy Now | 460.75% | Craig-Hallum | Albert Lowe32% | → $6 | Initiates | → Buy | Get Alert |
| 04/01/2025 | Buy Now | 647.66% | Jones Trading | — | $9 → $8 | Maintains | Buy | Get Alert |
| 04/01/2025 | Buy Now | 647.66% | HC Wainwright & Co. | Matthew Caufield52% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 647.66% | HC Wainwright & Co. | Matthew Caufield52% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 647.66% | HC Wainwright & Co. | Matthew Caufield52% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Opus Genetics (IRD) stock?
The latest price target for Opus Genetics (NASDAQ:IRD) was reported by Craig-Hallum on April 11, 2025. The analyst firm set a price target for $6.00 expecting IRD to rise to within 12 months (a possible 460.75% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Opus Genetics (IRD)?
The latest analyst rating for Opus Genetics (NASDAQ:IRD) was provided by Craig-Hallum, and Opus Genetics initiated their buy rating.
When was the last upgrade for Opus Genetics (IRD)?
There is no last upgrade for Opus Genetics
When was the last downgrade for Opus Genetics (IRD)?
There is no last downgrade for Opus Genetics.
When is the next analyst rating going to be posted or updated for Opus Genetics (IRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Opus Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Opus Genetics was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
Is the Analyst Rating Opus Genetics (IRD) correct?
While ratings are subjective and will change, the latest Opus Genetics (IRD) rating was a initiated with a price target of $0.00 to $6.00. The current price Opus Genetics (IRD) is trading at is $1.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
